Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anlotinib in Advanced Malignancy
NCT04216082Phase 2Completed
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Aug 2013
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of anlotinib in advanced cancer, sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started Aug 2013; status: completed.
02
Drugs
anlotinib
03
Conditions
advanced cancer
Beyond the preview
Go deeper on NCT04216082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04216082.